Treatment for basal cell carcinoma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8835394
SERIAL NO

13276068

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GRACEWAY PHARMACEUTICALS LLC340 EDGEMONT AVENUE SUITE 500 BRISTOL TN 37620

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fox, Terrance L Oakdale, US 7 387
Ginkel, Angela M St. Paul, US 4 167
Owens, Mary L Cottage Grove, US 9 400

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 16, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00